Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Operating Leases (2019 - 2025)

Bio Key International's Operating Leases history spans 6 years, with the latest figure at $28967.0 for Q3 2025.

  • For Q3 2025, Operating Leases fell 40.99% year-over-year to $28967.0; the TTM value through Sep 2025 reached $28967.0, down 40.99%, while the annual FY2024 figure was $48994.0, N/A changed from the prior year.
  • Operating Leases for Q3 2025 was $28967.0 at Bio Key International, down from $48994.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $118800.0 in Q3 2021 and bottomed at $22004.0 in Q2 2022.
  • The 4-year median for Operating Leases is $49042.5 (2024), against an average of $59941.6.
  • The largest annual shift saw Operating Leases tumbled 78.61% in 2021 before it decreased 26.87% in 2022.
  • A 4-year view of Operating Leases shows it stood at $86974.0 in 2021, then plummeted by 56.51% to $37829.0 in 2022, then rose by 29.51% to $48994.0 in 2024, then plummeted by 40.88% to $28967.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Operating Leases are $28967.0 (Q3 2025), $48994.0 (Q4 2024), and $49091.0 (Q3 2024).